Form 4: Director Acquires Stock Options in Niagen Bioscience

Hamed Shahbazi, a Director at Niagen Bioscience, Inc., acquired stock options on June 24, 2026, as detailed in a recent SEC Form 4 filing.

Summary

• Hamed Shahbazi, a Director of Niagen Bioscience, Inc. (NAGE), acquired stock options on June 24, 2026.
• The transaction involved the acquisition of 31,746 stock options with an exercise price of $3.45.
• These options are exercisable starting June 24, 2027, and expire on June 23, 2036.
• The underlying securities are 31,746 shares of Common Stock.
• Shahbazi beneficially owns these securities directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports a standard transaction of stock options by a director, which is common practice and does not inherently signal positive or negative news about the company's performance.

Positives

• Director acquisition of stock options can signal confidence in the company's future prospects.
• The acquisition of 31,746 options indicates a significant stake in potential future equity value.

Future Outlook

The filing does not contain forward-looking statements or guidance regarding future financial performance. It solely reports a transaction by a director.

Industry Context

StockSavvy.ai notes that director stock option grants are common in the biotechnology sector as a means of aligning executive interests with shareholder value and incentivizing long-term performance, especially for growth-oriented companies like Niagen Bioscience.

Stakeholder Impact

• Shareholders: The acquisition of options by a director may be viewed positively as it aligns management's interests with potential future stock price appreciation. However, the dilutive effect of future share issuance upon exercise should be considered.

Next Steps

• The stock options will vest on June 24, 2027.
• The stock options will expire on June 23, 2036.

Key Dates

Keywords

Niagen Bioscience, NAGE, Form 4, Stock Options, Director, Beneficial Ownership, SEC Filing